Latest Breaking News On - Proprietary portfolio highlights - Page 1 : comparemela.com

Completed acquisition of Trawsfynydd and concurrent $14 million Capital Raise Excellent pipeline progress, led by candidates for COVID 19, influenza, and oncology programs Poised to initiate Phase 2.

Traws pharmaMark guerinBruce mackleWerner cautreelsTorrey pinesSecurities exchangeExchange commissionLifesci advisorsTraws pharma incChief executive officerProprietary portfolio highlightsOrbimed private investmentsSecurities actSecurities exchange actPrivate securities litigation reform actSci advisors